Hyperkeratotic skin condition treatments and compositions
AssigneeCMPD Licensing, LLC
InventorJay Richard Ray, II
Life of this patent
Estimating the term…
Abstract
A method of treating a hyperkeratotic skin condition includes combining contents of a compounded capsule with corticosteroid cream or ointment that includes a high potency corticosteroid to formulate a topical composition for application to a skin area affected by hyperkeratosis. The contents of the capsule may include urea powder, and the corticosteroid cream or ointment may include Clobetasol Propionate Cream or Ointment, Diflorasone Diacetate Cream or Ointment, Amcinonide Cream or Ointment, Betamethasone Dipropionate Cream or Ointment, Desoximetasone Cream or Ointment, Fluocinonide Cream or Ointment, Halcinonide Cream or Ointment, Halobetasol Propionate Cream or Ointment, Mometasone Furoate Cream or Ointment, Flurandrenolide Cream or Ointment, or a combination thereof.
Claims4
A method of formulating a topical composition for treatment of a hyperkeratotic skin condition, the method comprising:
- combining contents of a compounded capsule with a corticosteroid cream to formulate a topical composition for application to a skin area affected by hyperkeratosis,
- wherein the contents of the capsule comprise urea bulk powder, and
- wherein the step of combining the contents of the compounded capsule with the corticosteroid cream comprises stirring or folding the urea bulk powder into the corticosteroid cream,
- wherein the corticosteroid cream comprises Clobetasol Propionate Cream, 0.05%, comprising cetyl alcohol, citric acid, glycol stearate, lanolin oil, methylparaben, PEG-8 stearate, polysorbate 60, propylene glycol, propylparaben, purified water, sodium citrate, stearyl alcohol, and white petrolatum, and
- wherein the topical composition comprises between approximately 2.5% and approximately 50% urea by weight and between approximately 0.0250% and approximately 0.0488% clobetasol propionate by weight.
A method of treating a hyperkeratotic skin condition, the method comprising:
- using a kit for treatment of a hyperkeratotic skin condition, the kit comprising
- a compounded capsule containing urea bulk powder and
- a corticosteroid ointment comprising clobetasol propionate,
- stirring or folding the urea bulk powder contents of the compounded capsule with the corticosteroid ointment to formulate a topical composition comprising between approximately 2.5% and approximately 50% urea by weight and between approximately 0.0250% and approximately 0.0488% clobetasol propionate by weight,
- wherein the corticosteroid ointment comprises Clobetasol Propionate Ointment, 0.05%, comprising propylene glycol, sorbitan sesquioleate, and white petrolatum,
- and applying the topical composition to a skin area affected by hyperkeratosis.
Dependencies are inferred from the claim text.